How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
First-in-Human Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Description:
This study is being done to determine if the investigational radiotracer called 111In-XYIMSR-01 is helpful in detecting clear cell renal cell carcinoma tissue in your body when used during a SPECT-CT Scan
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contacts:
Jasmine Brooksjbrook54@jhmi.edu
Yasser Ged, MBBSyged1@jhmi.edu
410-955-8893
Government Study Link:
NCT07062549 - Click here to see study onClinicalTrials.gov
111In-XYIMSR-01
Isotope(s):
Target(s):
- CAIX
Chelator: DOTA
